Burgess Laboratory

Current Team Members

Carmen

Carmen Zhang


Lab Manager

Education background
  • University of Melbourne, Melbourne, Australia, B.S. with Honors
  • Sun Yat-sen (Zhongshan) University, Guangzhou, China, B.S.
Work History
  • In vitro and in vivo performance testing of complex drug delivery systems
  • Cellular uptake and intracellular trafficking of nanoparticles
  • Immunohistochemistry and microscopy techniques
  • Long-Standing molecular biology experience
  • Evaluation of compound mitochondrial toxicity in the preclinical phase of drug development and assessing hepatic drug metabolism through P450 isoforms
Michail Kastellorizios

Michail Kastellorizios


Post-doctoral Fellow

Education background
  • University of Connecticut, Storrs. Ph.D.(2015)
  • University of Patras, Greece. Bachelor's in Pharmacy; M.Sc.
Research interest
  • Drug delivery (polymeric microspheres, hydrogels, liposomes, emulsions)
  • In vivo Metabolic Monitoring
  • Angiogenesis
Quanying

Quanying Bao


Post-doctoral Fellow

Education background
  • B.S. China Pharmaceutical University(2015)
  • M.S. China Pharmaceutical University
  • Ph.D. China Pharmaceutical University
Work Experience
  • 2013-2015, Scientist of Dept. of Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, Shanghai, China.
  • 2008-2009, Formulation research, Nanjing Sanhome Pharmaceuticals Co. Ltd.
Minsung Suh

Minsung Suh


Graduate Student

Education background
  • Korea University, Seoul, Korea, B.S. & M.S.
Research interest
  • Polymer-based drug delivery systems
  • siRNA delivery
  • anti-Cancer therapeutics
Rajan

Rajan Jog


Graduate Student

Education background
  • L.M.College of Pharmacy, Ahmedabad, Gujarat, India, B.Pharm.
  • National Institute of Pharmaceutical Education and Research, Mohali, Punjab, M.S.Pharm
Research interest
  • Nanoparticulate Drug Delivery System– Nanosuspensions and novel techniques involved for preparation & analysis
  • Targeted Drug Delivery System– Liposome Formulations – development, optimization & stability
  • Solid state stability studies– Effect of temperature, humidity and light on drug substance & drug product
Namita

Namita Tipnis


Graduate Student

CRS CT student chapter, Treasurer (2013)

Education background
  • Gahlot Institute of Pharmacy, University of Mumbai, Navi Mumbai, India, Bachelor of Pharmacy
  • Northeastern University, Boston, USA, MS
Research interest
  • In vitro dissolution studies of microspheres
  • Polymeric drug delivery systems
  • Drug device combination products-biosensors
Janki

Janki Andhariya


Graduate Student

Secretary, UConn AAPS Student Chapter (2015)

Education background
  • B.Pharm, L.M.College of Phamacy, Ahmedabad, Gujarat, India
  • M.Pharm, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, India
Research interest
  • Drug delivery systems
  • Formulation stability testing
  • Dissolution testing/In vitro drug release testing
  • In vitro in vivo correlation
Claire

Claire Price


Graduate Student

Education background
  • Pathobiology, University of Connecticut, B.S.
Research interest
  • Angiogenesis and tissue engineering
Anand

Anand Gupta


Graduate Student

Education background
  • B. Pharm, Pune University, Maharashtra, India
  • M. Pharm, Pune University, Maharashtra, India
Research interest
  • Nanoparticulate Drug Delivery Systems
  • Lipid based targeted drug delivery systems

Alumni

Jie Shen

Jie Shen


Assistant Professor

College of Pharmacy

University of Rhode Island

Education background
  • Fudan University, Shanghai, China, Post-doc Fellow
  • China Pharmaceutical University, Nanjing, China, M.S. & Ph.D.
Research interest
  • Polymeric microspheres
  • Targeted polymeric micelles for brain drug delivery
  • Thiolated lipid nanoparticles for ocular drug delivery
  • In vitro release testing for parenteral dosage forms
Antonio Costa

Antonio Costa


Biorasis Inc.

Education background
  • Ph.D.(2016), University of Connecticut, Pharmaceutics
  • Biomedical Engineering, University of Connecticut, B.S.,M.S.
  • German Studies, University of Connectict, B.A.
Research interest
  • Liposome drug delivery systems
  • Lipid-protein interactions
Bing Gu

Bing Gu


Pfizer

Education background
  • Ph.D.(2016), University of Connecticut, Pharmaceutics
  • School of Life Sciences, Fudan University, Shanghai, China, B.S.
  • School of Pharmacy, Fudan University, Shanghai, China, M.S.
Research interest
  • Standardized in vitro dissolution method
  • Targeted drug delivery systems
Sumit Kumar

Sumit kumar


Formulation Scientist

Allergan, Inc.

Education background
  • Ph.D. (2014), University of Connecticut, Pharmaceutics
  • Southern Illinois University, Illinois, M.S.
  • College of Pharmacy, Delhi, India. B.S.
Area of expertise
  • Formulation of Nanoparticles/Nanosuspensions
  • Spray drying
  • In-vitro Dissolution methods for pharmaceutical Nanoparticles
  • Atomic Force Microscopy
Yan Wang

Yan Wang


Staff Fellow

Office of Generic Drugs
FDA/Center for Drug Evaluation and Research

Education background
  • Ph.D. (2013), University of Connecticut, Pharmaceutics
  • China Pharmaceutical University, Nanjing, China, B.S. & M.S.
Area of expertise
  • Drug delivery system (microspheres and hydrogel)
  • Dissolution
  • Miniaturized biosensor and its in vitro/in vivo performance test
Mamta Kapoor

Mamta Kapoor


Staff Fellow

Office of Pharmaceutical Quality
FDA/Center for Drug Evaluation and Research

Education background
  • Ph.D. (2012), University of Connecticut, Pharmaceutics
  • College of Pharmacy (DIPSAR), New Delhi, India, B.Pharm.
  • National Institute of Pharmaceutical Education and Research (NIPER), Mohali, Punjab, India, M.S.
Area of expertise
  • Liposomes
  • siRNA
  • Gene delivery
  • Cell culture
Xiaoming Xu

Xiaoming Xu


Staff Fellow

Office of Pharmaceutical Quality
FDA/Center for Drug Evaluation and Research


Education background
  • Ph.D. (2012), University of Connecticut, Pharmaceutics
  • M.S. (2006), China Pharmaceutical University, Nanjing, China
  • B.S. (2003), China Pharmaceutical University, Nanjing, China
Areas of expertise
  • Application of Quality by Design (QbD) and Process Analytical Technology (PAT) in formulation and processing design
  • Pre-formulation and formulation development of oral controlled release dosage forms
  • Drug delivery systems
  • Mathematical modeling
  • In vitro drug release testing
Archana Rawat

Archana Rawat


Scientist

Teva Pharmaceuticals

Education background
  • Ph.D. (2011), University of Connecticut
  • Dehli University, New Dehli, India, M.S.
Areas of expertise
  • USP Apparatus 4
  • Standardized dissolution method
  • Microsphere
Upkar Bhardwaj

Jacqueline Morais


Principal Scientist

Johnson & Johnson, São Paulo, Brazil

Education background
  • Pharmaceutics, Ph.D. (2008), Universidade de São Paulo
  • Pharmacy, B.S. (2001),Universidade Federal de Goiás
Work background
  • Postdoctoral Fellow (2008-2010), University of Connecticut
  • University of Sao Paulo, Laboratory of Cosmetic Technology
  • Trainee Pharmaceutical Industry
Areas of expertise
  • Proficient in development of colloidal dosage forms (pharmaceutical and cosmetic applications)
  • Expertise in physicochemical characterization of dispersed systems such as surface properties and material flow properties Skilled in techniques of in vitro poorly soluble drug release from colloidal dosage forms including dialysis and flow-through methods
Sudhir

Sudhir Verma


Scientist

Millennium Pharmaceuticals, Cambridge, MA

Education background
  • Pharmaceutics, Dehli University, New Dehli, India, M.S.
  • Ph.D. (2010), University of Connecticut
Areas of expertise
  • Pre-formulation, formulation development and scale-up of oral controlled release dosage forms
  • Nanosuspensions, particle sizing, process optimization, dissolution, AFM, taste masking
Upkar Bhardwaj

Upkar Bhardwaj


Research Scientist

Forest Research Institute

Education background
  • Ph.D. (2009), University of Connecticut
  • M.Pharm. (2001), University of Delhi, New Delhi , India
  • B.Pharm. (1998), University of Delhi, New Delhi , India
Work background
  • 06/2012-present: Research Scientist at Forest Research Institute
  • 03/2009-06/2012: Sr Scientist at Novatis
Areas of expertise
  • Oral solid dosage forms
  • Modified release
  • Biopharmaceutics

Charudharshini Srinivasan


Staff Fellow

Office of Pharmaceutical Quality
FDA/Center for Drug Evaluation and Research

Education background
  • Ph.D. (2008), University of Connecticut
  • M. Tech. (2000), Institute of Technology, Banaras Hindu University
  • B. Pharm (1997), The Tamil Nadu Dr. M.G.R Medical University
Areas of expertise
  • Drug delivery and targeting
  • Membrane traffiking
  • Quantum dot
Banu Zolnik

Banu S. Zolnik


Senior Pharmacologist

Office of Pharmaceutical Quality
FDA/Center for Drug Evaluation and Research

Education background
  • Ph.D. (2005), School of Pharmacy, University of Connecticut
  • B.S. (1997), School of Pharmacy, Istanbul University, Istanbul, Turkey
Work background
  • 02/2008-present: Pharmacologist, Food and Drug Administration, CDER, Office of Pharmaceutical Quality
  • 11/2005-02/2008: Postdoctoral Fellow, Nanotechnology Characterization Laboratory, National Cancer Institute, SAIC-Frederick, MD
Areas of expertise

Research interests are related to regulatory aspects of the development of novel dosage drug delivery systems, such as nanoparticles, microspheres, emulsions, and liposomes. In addition, research interest include evaluation of bioequivalence for variety of therapeutics.

Hyungchui Kim

Hyungchui Kim


Associate Principal Scientist

AstraZeneca, Waltham MA

Education background
  • University of Connecticut
Work background
  • 2007-present: Associate Principle Scientist, Pharmaceutical Development, AstraZeneca
  • 2004-2007: Sr. Scientist, Pharmaceutical Development, Novartis, Cambridge MA
  • 2002-2004: Scientist, Vertex Pharmaceuticals, Cambridge MA
Siddhesh Patil

Siddhesh Patil


Scientist II

Millennium Pharmaceuticals, Cambridge, MA

Education background
  • Post-doc (2004) University of Connecticut
  • Ph.D. (2002) University of Connecticut
  • M.S. (2000) University of Connecticut
Work background
  • 2009-present: Senior Scientist, Millennium Pharmaceuticals: The Tekeda Oncology Company
  • 2006-2009: Development Scientist II, Amylin Pharmaceuticals
  • 2004-2006: Scientist: Protein & Small Molecule Formulation, Antigenics
Chidambaram Nachiappan

Chidambaram Nachiappan


Vice President

Lipocine Inc.

Education background
  • Ph.D. (2000), Pharmaceutics, University of Connecticut.
  • M.Pharm. (1993), Banaras Hindu University
  • B.Pharm. (1991), Annamalai University
Work background
  • 2014-present:Vice President
  • 2007-present: associate director at Lipocine Inc.
  • 2000-2007: group leader at Banner Pharmacaps Inc.
Onkar Singh

Stéphanie Ponsart Serrano


Regulatory Affairs Manager

Versonnex, France

Education background
  • Ph.D. (2000), Polymer chemistry : Chemistry – Biology Interface at Université Montpellier I
Work background
  • 2008-present: Regulatory Affairs Manager
  • 2005: R&D Project Manager, Anteis, Geneva
  • 2002: Assistant Professor, University of Paris XI, Faculty of Pharmacy-UMR CNRS 8612
Jamie Tsung

Jamie Tsung


Principal Scientist

Momenta Pharmaceuticals

Education background
  • Ph.D. (1999) University of Connecticut
Work background
  • 2008-2014: Senior Scientist, Shire, Lexington, MA
  • 2006-2008: Research Scientist, Process Development, Baxter Healthcare
  • 2004-2006: Development Scientist, UCB Inc.
  • 2002-2004: Senior Scientist, Lavipharm Laboratories Inc.
Onkar Singh

Tae Kim


Executive Managing Director

SAMIL Pharmaceuticals (Korea)

Education background
  • Ph.D. (1999), Biochemistry at Université Montpellier I.
Work background
  • 2011-present: Executive Managing Director of R&D, Samil Pharmaceuticals, South Korea
  • 2009-2011: Director of Clinical Science, Endo Pharm
  • 2007-2009: Associated Director of Clinical Science, Sandoz
  • 2001-2005: Sr. Scientist, Banner Pharmacaps
Allison Radwick

Allison Radwick


Adjunct Faculty

University of the Sciences, Philadelphia College of Pharmacy and Thomas Jefferson School of Pharmacy in Philadelphia, PA


Clinical Pharmacist

A.I duPont Hospital for Children in Wilmington, DE

Education background
  • Ph.D. (1999) in Pharmaceutical Sciences, University of Connecticut.
  • B.S. (1993) in Pharmacy with a Minor in Psychology at Philadelphia College of Pharmacy & Science (now University of the Sciences in Philadelphia)
Areas of expertise

Pharmacy Compounding including developing new processes and technologies to create innovative formulations, Curriculum Development of existing and new Pharmaceutical Science programs, Pharmacogenetics, Pharmacognosy, Natural Medicine

Kyung Ae Yoon

Kyung Ae Yoon


Patent Attorney

Yulchon Law Firm, Korea

Education background
  • Global Leadership Program in Graduate School of International Studies, Seoul National University (2011)
  • CASRIP Summer Institute, University of Washington (2006)
  • Univ. of Connecticut, College of Pharmacy, M.S.(1993) Ph.D. (1995)
  • Sungkyunkwan University, College of Pharmacy, B.Sc. (1981)
Work background
  • Yulchon LLC (2013-present)
  • Strategy Division Director, Member of Board of Directors, Patent Information Promotion Center (2011-2012)
  • International Business Division Director, Member of Board of Directors, Korean Institute of Patent Information (2009-2011)
  • Adjunct professor, Dept. of Pharmaceutical Science, Sungkyunkwan University, Seoul, Korea (2010)
  • Administrative Patent Judge, Korean Intellectual Property Tribunal (2009)
  • Technical Examiner, Patent Court (2008)
  • Director, Korean Intellectual Property Office, Pharmaceutical Chemistry Exam. Division (2006-2007)
  • Administrative Patent Judge, Korean Intellectual Property Intellectual Property Tribunal (2006)
  • Solicitor, Korean Intellectual Property Tribunal (2005-2006)
  • Senior Patent Examiner, Korean Intellectual Property Office, Pharmaceutical Chemistry Exam. Division (2004-2005)
  • Patent Examiner, Korean Intellectual Property Office, Pharmaceutical Chemistry Exam. Division (1999-2003)
  • Patent Examiner, Korean Intellectual Property Office, Fine Chemistry Exam. Division (1996-1999)
  • Lecturer, Sungkyunkwan University, College of Pharmacy (1996-1998)
  • Lecturer, Chosun University, Dept. of Polymer Science and Engineering (1996)
  • Pharmacist, Seoul National University Hospital (1982-1984)
Onkar Singh

Onkar N. Singh


Assistant Director, Development
CMC Team Leader

Alcon Laboratories, Inc.
(Division of Novatis)

Education background
  • M.B.A. (2004), College of Bussiness Administration, University of Texas at Arlington, TX
  • Ph.D. (1992), Department of Pharmaceutical Sciences, University of Illinois at Chicago. Thesis Title: "Complex Coacervate Microencapsulation for Protein Drug Delivery"
  • M.Pharm. (1984), Banaras Hindu University, India
  • B.Pharm. (1982), Banaras Hindu University, India
Work background
  • 1995-present: Alcon Laboratories, Inc. (Division of Novatis)
  • 1992-1995: Access Pharmaceuticals, Inc.